Management of Suspected Amoxicillin-Clavulanate Allergy

Immediate Clinical Actions

• The American College of Allergy, Asthma, and Immunology recommends immediately discontinuing Augmentin and initiating symptomatic treatment with oral antihistamines and topical corticosteroids for a likely delayed-type hypersensitivity reaction 1, 2

Critical Assessment for Severity

• The Infectious Diseases Society of America suggests examining for warning signs of severe reactions, such as purple bullae, skin sloughing, mucosal involvement, facial edema, or systemic toxicity 3

Documentation and Allergy Labeling

• The Journal of Allergy and Clinical Immunology recommends documenting the specific antibiotic, type of reaction, severity, timing, and management in the medical record 2, 3, 4
• The American Academy of Allergy, Asthma, and Immunology suggests adding "amoxicillin-clavulanate allergy" to all medical records and providing the patient with written documentation, specifically labeling it as a delayed, non-severe reaction 1, 2, 4

Future Antibiotic Selection

• The Clinical Microbiology and Infection guidelines recommend avoiding all amoxicillin-containing products and considering cephalosporins with dissimilar R1 side chains, macrolides, fluoroquinolones, or trimethoprim-sulfamethoxazole as safe alternatives 1, 3, 4, 5

Common Pitfalls to Avoid

• The Journal of Allergy and Clinical Immunology advises against assuming a delayed rash represents true IgE-mediated allergy and against avoiding all beta-lactams unnecessarily, as most cephalosporins and carbapenems can be safely received based on side-chain differences 4
• The Clinical Microbiology and Infection guidelines suggest not rechallenging within 1 year and ensuring the allergy label specifies "delayed, non-severe" to prevent unnecessary broad-spectrum antibiotic use 1, 2, 4